FindTrial
Sign In

A study to associate aggressiveness of cholesteatoma

ASSOCIATION OF AGGRESSIVENESS OF CHOLESTEATOMA IN PATIENTS WITH CHRONIC OTITIS MEDIA SQUAMOSAL DISEASE USING MIDDLE EAR RISK INDEX, miRNA 21, IL-6 GENE EXPRESSION - COM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041598
Enrollment
30
Registered
2022-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H711- Cholesteatoma of tympanum

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

DEAN Research committe
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ALL PATIENTS WITH CHRONIC OTITIS MEDIA SQUAMOSAL DISEASE WITH CHOLESTEATOMA

Exclusion criteria

Exclusion criteria: ALL PATIENTS WITH: CHRONIC OTITIS MEDIA MUCOSAL DISEASE EXTERNAL AUDITORY CANAL CHOLESTEATOMA SKULL BASE OSTEOMYELITIS SYSTEMIC INFLAMMATORY OR MALIGNANT CONDITIONS

Design outcomes

Primary

MeasureTime frame
AGGRESSIVENESS OF CHOLESTEATOMA USING miRNA 21 and IL-6Timepoint: POST OPERATIVELY—

Secondary

MeasureTime frame
Correlation between Middle Ear Risk Index and miRNA 21 & IL-6 gene expressionTimepoint: Post surgery—

Countries

India

Contacts

Public ContactKARTHIKEYAN M

AIIMS JODHPUR

meetugoyal@yahoo.com9649954000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026